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A caldesmon kinase activity was detected in an ATP extract of the myofibril-like pellet from sheep aorta. The enzyme was purified 745-fold and 
was identified as casein kinase II on the basis of molecular size, substrate specificity, and high sensitivity to heparin inhibition. Casein kinase II 
phosphorylated isolated caldesmon and caldesmon i corporated into native thin filaments, and transferred about 1 tool of phosphate per mol of 
caldesmon-h. Ser-73 was the main site phosphorylated by casein kinase II in chicken gizzard caldesmon. Phosphorylation f caldesmon reduced 
its affinity for smooth muscle myosin but had no effect upon the ability of caldesmon to inhibit the ATPase activity of actomyosin. 
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1. INTRODUCTION 
Caldesmon is a calmodulin- and actin-binding pro- 
tein that is a component of the thin filaments in smooth 
muscles. This protein seems to play a role in Ca2+-de - 
pendent regulation of smooth muscle contraction (for 
review see [1,2]), supplementing the well-established 
myosin phosphorylation mechanism. 
It is well known that caldesmon can be phos- 
phorylated in vitro by many protein kinases and that 
such phosphorylation can modulate caldesmon func- 
tion [1,3]. However, work in vivo has only produced 
convincing evidence of a role for MAP kinase in phos- 
phorylating caldesmon in arterial smooth muscle [4,5]. 
One way to determine which kinase is important in 
phosphorylating caldesmon in vivo is to assay the cal- 
desmon phosphorylating activity in smooth muscle ho- 
mogenates. We have investigated a crude extract of 
sheep aorta actomyosin for caldesmon phosphorylating 
activity. In initial work we identified kinase activity that 
precipitated in 65-80% saturated ammonium sulphate 
[6]. This activity has recently been identified as being 
due to a proteolytic fragment of protein kinase C [7]. 
When precautions were taken to exclude phosphatase 
activity it was found that a much larger caldesmon 
phosphorylating activity precipitates at 3045% satu- 
rated ammonium sulphate. We have therefore purified 
this caldesmon phosphorylating enzyme and investi- 
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gated its properties. We have found that this enzyme is 
casein kinase II and that it could be one of the en- 
dogenous protein kinases involved in caldesmon phos- 
phorylation in vivo. 
2. MATERIALS AND METHODS 
2. t. Materials 
[y-32p]ATP was obtained from Amersham. Other reagents of ana- 
lytical grade were from Sigma or BDH. c~-Chymotrypsin type VII, 
histone III-S and c~-casein were obtained from Sigma; okadaic acid 
from Kamiya Biomedical Co. 
2.2. Isolation of caldesmon phosphorylating activity 
Crude actomyosin was prepared from sheep aorta smooth muscle 
[8] and the thin filaments were sedimented from the actomyosin the 
presence of 20% ethylene glycol as described in[9]. Kinase activity was 
left behind in the supernatant that was dialysed for 3 h against 2 1 of 
20 mM HEPES, pH 7.3, 0.1 M KC1, 5 mM MgClz, 1 mM EGTA, 10 
mM 2-mercaptoethanol, 0.1 mM PMSF, and 1/~g/ml each ofleupeptin 
and chymostatin to reduce the concentration f ethylene glycol, and 
subjected to ammonium sulphate fractionation. The fraction which 
precipitated at30~5% of ammonium sulphate possessed the highest 
caldesmon kinase activity and was subjected to further purification by 
gel-filtration on Sepharose CL-4B followed by chromatography on 
Q-Sepharose and P-cellulose (Fig. 1). 
2.3. Purification of other proteins 
Sheep aorta and chicken gizzard caldesmon were purified by the 
Bretscher method [10] with slight modifications [6]. Sheep aorta 
myosin was purified and thiophosphorylated according to [11]. The 
method of Weeds and Taylor [12] was used for preparation ofskeletal 
muscle HMM. Sheep aorta thin filaments, mooth and skeletal muscle 
actin and smooth muscle tropomyosin were isolated as described in 
[9]. The N-terminal fragment of chicken gizzard caldesmon containing 
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the first 128 amino acid residues (N-128) and 658C (C-terminal 99 
amino acids) were expressed in E. coli [13]. Fragment H1 (human 
caldesmon C-terminal 288 amino acids) was supplied by Dr. P. Huber 
[141. 
2.4. Protein phosphorylation 
Phosphorylation was performed inthe buffer containing 8 mM Tris, 
12 mM KHzPO4, 6 mM MgC12, 0.1 mM EGTA, 30 100 mM NaC1, 
5 mM 2-mercaptoethanol, 30-70 /IM [y-32p]ATP (300-2,000 cpm/ 
pmol), 0.1-0.4 mg/ml of protein substrate and 0.6-2 ~tg of the enzyme. 
After incubation at 30°C for appropriate imes, 2040/11 of incubation 
mixture was spotted on Whatman 3MM filters. Filters were washed 
and counted as in [15]. To obtain preparative quantities of 
phosphorylated proteins, 1 3 mg/ml of caldesmon or N-128 were 
incubated in the above mentioned buffer with a slightly increased 
concentration f ATP (70-150/tM) for 6-14 h at 30°C. 
Native thin filaments were suspended in 20 mM Tris-HC1, pH 7.5, 
70 mM KC1, 10 mM 2-mercaptoethanol and 0.1 mM PMSF and 
dialysed against he same buffer to remove ATE Thin filaments (2 
mg/ml) were incubated with the kinase in the presence of5 mM MgC12, 
5 nM okadaic acid and 2 mM [T-32p]ATP (150 cpm/pmol) at 30°C for 
20 min. 
2.5. Binding of caldesmon and N-128 to myosin 
Caldesmon (34/ IM)  or N-128 peptide (8 12 ,uM) were co-sedi- 
mented with thiophosphorylated gizzard myosin filaments (~12/~M) 
by centrifugation in a Beckman Airfuge at 30 psi for 30 rain. The initial 
sample, supernatant and pellet were separated by electrophoresis on 
8-30% polyacrylamide/0.1% SDS gels (Pharmacia Excelgel). The 
quantity of caldesmon orits peptide remaining inthe supernatant after 
ultracentrifugation was determined by quantitative scanning of the 
Coomassie blue-stained gels. The radioactivity of phosphorylated cal- 
desmon or its peptide remaining in the supernatant was determined 
either by (~erenkov's method or by quantitative scanning of the corre- 
sponding autoradiographs [16]. 
2.6. Measurements of ATPase activity 
The acto-HMM ATPase activity was determined in buffer contain- 
ing 5 mM KzPIPES (pH 7.0), 2.5 5 mM MgCI:, 1 mM dithiothreitol, 
and either 5 mM (low ionic strength) or 70 mM (high ionic strength) 
KCI at 37°C, according to our usual method [13]. 
2.7. Determination of the sites of phosphorylation 
32P-Phosphorylated caldesmon was precipitated byaddition of TCA 
to the final concentration f 5% and the pellet was washed 5times with 
5% TCA followed by 3 washes with diethyl ether. The dried radioac- 
tive protein was suspended in 50 mM NH4HCO3, containing 100 ,uM 
CaCI 2 and 1 mM dithiothreitol, and hydrolyzed by TPCK-treated 
trypsin (weight ratio caldesmon:trypsin equal to 50:1) for 4.5 h. The 
resultant clear solution was loaded on 4.6×250 mm Vydac 
218TP54C~8 reverse phase column and HPLC was performed as in 
[17]. Well-separated radioactive peptides were sequenced on an Ap- 
plied Biosystems model 477A sequencer quipped with on-line model 
120A phenylthiohydantoin (PTH) analyzer, as described earlier [17]. 
2.8. Other methods 
Caldesmon concentration was determined from absorbance meas- 
urement at 280 nm. E%~ for caldesmon was taken to be equal to 0.33 
and its molecular weight equal to 87 kDa [18]. Other protein concen- 
trations were determined by the Lowry method. 
RESULTS AND DISCUSSION 
3.1. Purification of endogenous caldesmon kinase from 
sheep aorta 
Sheep aorta was homogenised and washed twice in a 
low ionic strength, Triton X-100-containing buffer. The 
resulting pellet contained most of the contractile pro- 
teins which were then solubilised in 80 mM KC1/10 mM 
ATP solution [8]. Native thin filaments were separated 
from this crude actomyosin extract by ultracentrifuga- 
tion in the presence of 20% glycol; the pellet contained 
actin tropomyosin and caldesmon i  a ratio of 16:2:1 
[9,19], but negligible caldesmon phosphorylating activ- 
ity, as previously observed [11]. Caldesmon phospho- 
rylating activity was abundant in the supernatant frac- 
tion; the bulk of the activity was precipitated in a 30- 
45% saturated ammonium sulphate fraction. About 10% 
of the activity precipitated in the range of 65-80% am- 
monium sulphate saturation, as previously found [6], and 
this activity was identified as being due to a constitutively 
active proteolytic fragment of protein kinase C [7]. 
The major endogenous caldesmon phosphorylating 
activity was purified from the P30-45% fraction (Fig. 
1). On a Sepharose 4B column the caldesmon kinase 
activity was eluted in a single wide peak and the enzyme 
was separated from myosin. Fractions with the highest 
protein kinase activity were further purified by ion-ex- 
change chromatography on Q-Sepharose (Fig. 1B). Al- 
though this step of purification was rather effective 
(yielding a 7.5-fold increase in specific activity) we were 
unable to separate protein kinase from tropomyosin. 
The final and most effective step of purification con- 
sisted of cation-exchange chromatography on phospho- 
cellulose in the presence of high NaC1 concentrations. 
Under these conditions most of the proteins (including 
tropomyosin) did not interact with phospho-cellulose, 
whereas caldesmon kinase did (Fig. 1C) permitting a
stepwise elution. Alternatively the phospho-cellulose 
column was developed with a linear (0.4-0.8 M) gradi- 
ent of NaC1 in buffer B (20 mM Tris-HC1, pH 7.5, 1 mM 
EDTA, 1 mM EGTA, 5 mM mercaptoethanol, 0.1 mM 
PMSF). In this case protein kinase was eluted at around 
0.6 M NaC1. The final product had a specific activity of 
22 nmol Pi/min/mg caldesmon, 745-times greater than 
the crude actomyosin starting material. Fractions pos- 
sessing caldesmon kinase activity were concentrated 
against 20% polyethyleneglycol in buffer B and stored 
at -20°C in 50% glycerol. 
3.2. Identification of the endogenous kinase as casein 
kinase H 
3.2.1. Chromatographic properties 
This enzyme has a high molecular weight (Fig. 1A), 
is strongly bound to Q-Sepharose (Fig. 1B) and inter- 
acts extremely tightly with phospho-cellulose (Fig. 1C). 
All these properties are similar to those of casein kinase 
II that has a molecular weight of about 130-140 kDa, 
tends to aggregate at .tow ionic strength, and binds 
tightly to both anion- and cation-exchangers [20~22]. 
3.2.2. Substrate specificity 
When we analyzed the substrate specificity of cal- 
desmon kinase from aorta we found that of the sub- 
19 
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strates tested, casein was phosphorylated at the highest 
rate whereas histone III-S, smooth muscle myosin, tro- 
pomyosin and actin were phosphorylated at a very low 
rate (Table I). It is known that casein kinase II preferen- 
tially phosphorylates acidic protein substrates such as 
casein and phosvitin [22]. The endogenous caldesmon 
kinase effectively phosphorylated both chicken gizzard 
and aorta caldesmon (Table I). This agrees with our 
demonstration that casein kinase II is able to phospho- 
rylate caldesmon [15,16]. 
Casein kinase II is distinguishable from other protein 
kinases by its ability to use both ATP and GTP as 
substrates [21,22]. The K m value for GTP is only 2- to 
4-times higher than that for ATP [22,23]. Addition of 
non-radioactive GTP (in the micromolar range) to the 
incubation mixture containing [y-32p]ATP significantly 
decreased the rate of y_32p incorporation into cal- 
desmon by the enzyme isolated from sheep aorta (Table 
I), suggesting that this enzyme can use GTP as an alter- 
native substrate. 
3.2.3. Inhibition by heparin 
Heparin and other sulfated glycosaminoglycans are 
potent inhibitors of casein kinase II [24] at concentra- 
tions lower that 1/lg/ml which do not affect other pro- 
tein kinases [21,22]. We found that heparin effectively 
inhibited aorta caldesmon kinase (Table I). The ICs0 
was found to be 0.35/lg/ml; this value agrees well with 
the ICs0 determined for casein kinase II [22]. 
3.2.4. Phosphorylation site on caldesmon 
There is a consensus sequence for casein kinase II in 
both gizzard and mammalian (human) caldesmon se- 
quences: 735XXE (gizzard) and 73SXXD (human) 
[21,25]. We have previously shown that casein kinase II 
from liver phosphorylates gizzard caldesmon uniquely 
at Ser-73 [16], whereas most other kinases phospho- 
___) 
Fig. 1. Purification of caldesmon kinase. (A) Gel-filtration. The P30- 
45 fraction was dissolved in a small volume of buffer A containing 20 
mM Tris-HCl, pH 7.5, 0.4 M KC1, 2.5 mM MgC12, 1 mM EGTA, 10 
mM 2-mercaptoethanol and 0.1 mM PMSF and 5 ml sample was 
applied on the Sepharose 4B column (1.6 x 90 cm) equilibrated with 
the same buffer. 4.2 ml fractions were collected and the caldesmon 
kinase activity was determined. (B) Q-Sepharose chromatography. 
Fractions with the highest protein kinase activity were mixed, diluted 
twice with buffer B (20 mM Tris-HCl, pH 7.5, 1 mM EDTA, 1 mM 
EGTA, 5 mM mercaptoethanol, 0.1 mM PMSF) and applied on the 
Q-Sepharose Fast Flow column (1.6 x 10 cm) equilibrated with buffer 
B, containing 0.2 M NaC1. After washing with buffer B proteins were 
eluted by stepwise increases in NaC1 concentration (0.2, 0.32, 0.5 and 
1 M). Caldesmon kinase was eluted with buffer B containing 0.5 M 
NaCI. (C) Phospho-cellulose chromatography. The fractions obtained 
after Q-Sepharose chromatography were diluted twice with buffer B 
and loaded on a phospho-cellulose (Whatman P-11) column (1.6 x 5 
cm) equilibrated with buffer B containing 0.2 M NaCI. The column 
was washed with buffer B with 0.4 M NaC1, and caldesmon kinase was 
eluted with buffer B containing 0.7 M NaCI. (--) optical density at 280 
nm; (e) caldesmon phosphorylating activity. 
rylate at multiple sites or phosphorylate atthe C-termi- 
nus of caldesmon [1,3]. We found that the endogenous 
caldesmon kinase mainly phosphorylated N-terminal 
caldesmon fragments in tryptic digests of 
phosphorylated caldesmon, as in [16]. The expressed 
caldesmon fragment N-128 (amino acids 1-128) was 
much better phosphorylated than the C-terminal frag- 
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Fig. 2. Phosphorylation of aorta native thin filaments by smooth 
muscle casein kinase II. Phosphorylation was performed as described 
in section 2. (A) Coomassie blue-stained gel; (B) autoradiograph. FL, 
filamin; HMM, myosin heavy chains; CaD, caldesmon; A, actin; TM, 
tropomyosin; MLC, myosin light chain. 
ments 658C and H1 (Table I). Finally the major phos- 
phorylation site was positively identified as Ser-73 by 
sequencing tryptic peptides of phosphorylated gizzard 
caldesmon, as we previously showed with liver casein 
kinase II [17]. 
We were not able to determine the site of phosphoryl- 
ation in sheep aorta caldesmon since the yield of 
phosphopeptides was very low and the tryptic 
phosphopeptides of aorta caldesmon had a blocked N- 
terminus. This is probably a consequence of sequence 
differences between sheep and chicken [25]. 
3.3. Effects of casein kinase H phosphorylation upon cal- 
desmon function 
Sheep aorta casein kinase II phosphorylated cal- 
desmon equally well when pure and when incorporated 
into the native thin filaments (Figs. 2 and 3). However, 
phosphorylation had no detectable ffect upon cal- 
desmon inhibition of actin tropomyosin activation of 
myosin MgATPase activity, which is a sensitive indica- 
tor of the caldesmon-actin-tropomyosin interaction; 
these functions are known to be associated with the 
C-terminus of caldesmon [1,13]. 
Myosin binding involves both N- and C-terminal 
sites in caldesmon [13,14,26,27] and we found, as in our 
previous work with liver casein kinase II, that 
phosphorylated caldesmon bound smooth muscle 
myosin weaker [16]. This effect was particularly marked 
when myosin binding to the isolated N-terminus (N- 
128) containing Ser-73 was measured (Fig. 4). 
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Fig. 3. Phosphorylation f caldesmon by smooth muscle casein kinase 
II. Time-~zourse of aorta caldesmon phosphorylation. 0.4 mg/ml cal- 
desmon, 50 ,ug/ml purified casein kinase II, 30°C. Conditions as de- 
scribed in section 2. 
3.4. Possible physiological significance 
Whilst casein kinase II is reported to be abundant in 
spleen, testis, liver and kidney, much smaller quantities 
are present in striated muscle tissue [28-30]. Little has 
been published on casein kinase II from smooth muscle 
[31,32], but it has been assumed that the properties are 
similar to that of the enzymes purified from other tis- 
sues, and this is in accord with our results (Table I). 
In the crude actomyosin which was the starting mate- 
rial for our isolation, casein kinase II was the most 
abundant caldesmon phosphorylating activity and cal- 
Table I 
Effects of substrate and inhibitors on activity of purified caldesmon 
phosphorylating enzyme 
Substrate Relative phosphorylation 
rate 
Casein 100 
Casein + 0.18 pg/ml heparin 61 
Casein + 0.36 pg/ml heparin 26 
Casein + 80 pM GTP 55 
Caldesmon 82 
Caldesmon N-terminus, gizzard 1-128 75 
(N-128) 
Caldesmon C-terminus, gizzard 658-756 12 
(658C) 
Caldesmon C-terminus, human 50~793 (HI) 21 
Smooth muscle myosin 5 
Smooth muscle myosin (thio- 6 
phosphorylated) 
Smooth muscle tropomyosin 3 
Actin 4 
Histone III-S 7 
All protein substrates at concentration of 0.4 mg/ml were 
phosphorylated for 10 min under conditions described in section 2. 
The rate of casein phosphorylation was taken as 100%. 
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Fig. 4. Effect of phosphorylation f chicken gizzard caldesmon N-128 
fragment on its binding to smooth muscle myosin. Caldesmon N- 
terminal fragment, phosphorylated at a level of 0.1 mol 32p per mol 
N-128, was mixed with myosin under conditions described in section 
2. After ultracentrifugation c centration (©) and radioactivity (e) in 
the supernatant were determined. The phosphorylated N-128 bound 
much weaker than the bulk of the protein, which was largely 
unphosphorylated. 
desmon is a lmost  as good a substrate for this enzyme 
as casein itself (Table I); however, we do not  know 
whether phosphory la t ion  by this enzyme occurs in vivo. 
As a rule, the turnover  ate of  phosphate  incorporated 
by casein k inase II is rather low [22], so we may suppose 
that ca ldesmon phosphory la t ion  is unl ikely to change 
rapidly. 
Measurements  of  ca ldesmon phosphory la t ion  i vas- 
cular smooth  muscle st imulated by phorbo l  d ibutyrate 
has provided posit ive evidence that ca ldesmon is 
phosphory la ted  by MAP kinase and has excluded sig- 
ni f icant phosphory la t ion  by CaZ+-ca lmodul in -depend - 
ent kinase II and  prote in  k inase C [4,5]. It is notab le  that 
an early report  also indicated that the N- terminus  of  
ca ldesmon became phosphory lated in vivo [33]. Since 
CaZ+-ca lmodul in -dependent  ki ase II was excluded it 
seems possible that this phosphory la t ion  was due to the 
casein k inase I I  present in vascular  smooth  muscle. I f  
so this phosphory la t ion  might  be expected to modu la te  
the abi l i ty o f  ca ldesmon to cross- l ink thick and  thin 
f i laments [26,34]. 
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